Search Orphan Drug Designations and Approvals
-
| Generic Name: | Recombinant AAV9 vector encoding the human progranulin (PGRN) gene |
|---|---|
| Date Designated: | 11/24/2021 |
| Orphan Designation: | Treatment of frontotemporal dementia (FTD) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
AviadoBio Ltd. 86 Hatton Garden Floor 5 London, London EC1N 8QQ United Kingdom The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







